A first-in-human phase 1 trial of CAR-Tregs for the treatment of Amyotrophic Lateral Sclerosis
Latest Information Update: 21 May 2025
At a glance
- Drugs CAR-TREGs PolTREG (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Adverse reactions; First in man
Most Recent Events
- 15 May 2025 According to a PolTREG media release, company intensively prepare to initiate a Phase 1 clinical trial in Amyotrophic-lateral-sclerosis in the coming months.
- 15 Mar 2024 New trial record
- 11 Mar 2024 According to a PolTREG media release, trial expects to start in early 2025.